Literature DB >> 25307984

Predictors of development of chronic vestibular insufficiency after vestibular neuritis.

Ivan Adamec1, Magdalena Krbot Skorić1, David Ozretić2, Mario Habek3.   

Abstract

OBJECTIVES: To evaluate the role of clinical parameters, MRI and ocular VEMP (oVEMP) and cervical VEMP (cVEMP) as predictors of development of chronic vestibular insufficiency after vestibular neuritis.
METHODS: Twenty-six patients with vestibular neuritis were included: 15 patients (58%) showed complete clinical recovery, and 11 patients (41%) were diagnosed with the syndrome of chronic vestibular insufficiency. Clinical parameters (vomiting, nystagmus, postural stability, and nausea) were assessed at diagnosis. MRI was performed within 3 months and VEMP within 6 days and at 1 year after the initial presentation. The amplitude asymmetry ratio (AR) was calculated using the following formula: AR=((healthy side-affected side)/(healthy side+affected side) × 100).
RESULTS: Of all studied parameters, only chronic white matter supratentorial lesions present on brain MRI negatively correlated with clinical recovery (Phi coefficient=-0.637, p=0.001). The logistic regression analysis showed that positive brain MRI and older age reduced odds for clinical recovery. There was no correlation between clinical recovery and oVEMP AR recovery between groups (p=0.781). Seven patients showed improvement, and 19 showed worsening on oVEMP AR after a 1-year follow-up. Statistical regression model for predicting the outcome of clinical recovery using asymmetry score recovery, as an independent variable, was not statistically significant.
CONCLUSIONS: Older age and chronic white matter lesions on brain MRI are positive predictors of development of chronic vestibular insufficiency after vestibular neuritis. VEMPs are not useful in predicting the development of chronic vestibular insufficiency.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Age; Cervical vestibular evoked myogenic potentials; Chronic vestibular insufficiency; MRI; Ocular vestibular evoked myogenic potentials; Vestibular neuritis

Mesh:

Year:  2014        PMID: 25307984     DOI: 10.1016/j.jns.2014.10.001

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Power spectra prognostic aspects of impulsive eye movement traces in superior vestibular neuritis.

Authors:  Alessandro Micarelli; Andrea Viziano; Massimo Panella; Elisa Micarelli; Marco Alessandrini
Journal:  Med Biol Eng Comput       Date:  2019-05-04       Impact factor: 2.602

2.  Predictors of clinical recovery from vestibular neuritis: a prospective study.

Authors:  Sian Cousins; Diego Kaski; Nicholas Cutfield; Qadeer Arshad; Hena Ahmad; Michael A Gresty; Barry M Seemungal; John Golding; Adolfo M Bronstein
Journal:  Ann Clin Transl Neurol       Date:  2017-03-22       Impact factor: 4.511

Review 3.  Neuro-otology- some recent clinical advances.

Authors:  Miriam S Welgampola; Gülden Akdal; G Michael Halmagyi
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

4.  Asymmetric vestibular stimulation reveals persistent disruption of motion perception in unilateral vestibular lesions.

Authors:  R Panichi; M Faralli; R Bruni; A Kiriakarely; C Occhigrossi; A Ferraresi; A M Bronstein; V E Pettorossi
Journal:  J Neurophysiol       Date:  2017-08-16       Impact factor: 2.714

5.  The influence of cerebral small vessel diseases on the efficacy of repositioning therapy and prognosis of benign paroxysmal positional vertigo.

Authors:  Jian Zang; Xuejun Jiang; Shuai Feng; Hongyang Zhang
Journal:  Int J Med Sci       Date:  2022-07-04       Impact factor: 3.642

6.  Are white matter abnormalities associated with "unexplained dizziness"?

Authors:  Hena Ahmad; Niccolò Cerchiai; Michelangelo Mancuso; Augusto P Casani; Adolfo M Bronstein
Journal:  J Neurol Sci       Date:  2015-09-04       Impact factor: 3.181

7.  An fMRI study of visuo-vestibular interactions following vestibular neuritis.

Authors:  R E Roberts; H Ahmad; M Patel; Danai Dima; R Ibitoye; M Sharif; R Leech; Q Arshad; A M Bronstein
Journal:  Neuroimage Clin       Date:  2018-10-09       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.